Casdin Capital, LLC Decibel Therapeutics, Inc. Transaction History

Casdin Capital, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$1.85 - $4.21 $610,500 - $1.39 Million	-330,000 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$2.83 - $5.03 $2.38 Million - $4.23 Million	-840,048 Reduced 71.8%	330,000 $1 Million
Q3 2021 Nov 15, 2021	SELL	$6.6 - $9.04 $9,061 - $12,411	-1,373 Reduced 0.12%	1,170,048 $9.02 Million
Q2 2021 Aug 16, 2021	BUY	$6.39 - $11.51 $159,750 - $287,750	25,000 Added 2.18%	1,171,421 $10.1 Million
Q1 2021 May 17, 2021	BUY	$10.56 - $19.9 $12.1 Million - $22.8 Million	1,146,421 New	1,146,421 $13 Million

Ticker DBTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 24,964,500
Description
Decibel Therapeutics, Inc., a clinical-stage biotechnology company, engages in discovering and developing transformative treatments for hearing and balance disorders. Its product candidates and programs focuses on three areas, such as Gene Therapies for Congenital, Monogenic Hearing Loss designed to restore functional cells within the cochlea to...

Get notified when there are updates to the investment portfolio of Casdin Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Casdin Capital, LLC with notifications on news.